Mednax Inc (MD)

Activity ratios

Short-term

Turnover ratios

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Inventory turnover 14.38 23.76 20.30 — — 26.71 — 17.45 — 23.02 16.96 16.91 — 0.48 135.13 105.43 — 6.62 2.25 1.76
Receivables turnover 7.17 7.10 7.22 6.97 6.32 6.05 5.58 5.73 5.76 6.24 6.14 6.48 8.77 9.00 7.40 6.74 6.80 6.92 6.82 6.69
Payables turnover 5.62 7.94 8.16 7.40 8.32 9.51 8.94 9.39 8.01 8.47 7.88 5.57 6.59 7.66 39.57 43.06 64.97 59.28 24.81 22.21
Working capital turnover 20.66 28.11 25.23 15.62 1,864.13 25.53 14.12 10.70 4.41 4.46 4.24 5.08 1.92 2.24 9.97 5.71 17.89 7.37 6.32 5.44

Based on the activity ratios data provided for Pediatrix Medical Group Inc, we can see the following trends:

1. Receivables Turnover: The receivables turnover ratio measures how efficiently the company collects payments from its customers. Pediatrix Medical Group Inc's receivables turnover has been relatively stable over the quarters, ranging from 6.43 to 7.37. This indicates that the company is effective in collecting payments from its customers.

2. Payables Turnover: The payables turnover ratio assesses how quickly a company pays off its suppliers. In this case, the payables turnover for Pediatrix Medical Group Inc is consistently reported as zero across all quarters. This could indicate that the company is not utilizing its credit terms with suppliers or has a different payment cycle.

3. Working Capital Turnover: The working capital turnover ratio measures how efficiently a company utilizes its working capital to generate sales. Pediatrix Medical Group Inc's working capital turnover has shown significant fluctuations, with a peak of 1,960.26 in Q4 2022 and varying between 11.45 to 28.71 in the following quarters. Such erratic movements could be due to factors impacting the company's working capital management.

In conclusion, while Pediatrix Medical Group Inc demonstrates strong efficiency in collecting receivables, the analysis of payables turnover and working capital turnover suggests a need for further investigation into the company's payment practices and working capital management strategies to ensure optimal operational efficiency.

Average number of days

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Days of inventory on hand (DOH) days 25.38 15.36 17.98 — — 13.67 — 20.92 — 15.86 21.52 21.58 — 753.76 2.70 3.46 — 55.16 161.87 207.25
Days of sales outstanding (DSO) days 50.90 51.39 50.59 52.37 57.76 60.36 65.43 63.72 63.36 58.49 59.47 56.32 41.61 40.54 49.31 54.17 53.65 52.74 53.50 54.55
Number of days of payables days 64.92 46.00 44.72 49.33 43.86 38.37 40.82 38.86 45.58 43.09 46.29 65.56 55.43 47.62 9.22 8.48 5.62 6.16 14.71 16.44

Days of inventory on hand (DOH) is not available from the provided table, indicating a lack of data on the average number of days the company holds inventory before it is sold.

Days of sales outstanding (DSO) decreased from 54.93 days in Q4 2022 to 51.21 days in Q4 2023. This suggests an improvement in the company's efficiency in collecting revenue from its customers over time.

The number of days of payables is not available, making it difficult to assess the company's efficiency in paying its suppliers and managing its working capital.

Overall, based on the available data, Pediatrix Medical Group Inc seems to be making progress in managing its accounts receivable efficiently, but more information on inventory and payables would provide a more comprehensive analysis of its working capital management.

Long-term

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Fixed asset turnover 25.81 26.22 26.65 26.64 25.59 25.66 25.42 25.11 25.95 24.02 24.83 21.26 27.85 33.22 30.83 33.84 46.70 36.53 37.10 39.27
Total asset turnover 0.88 0.85 0.85 0.84 0.80 0.79 0.77 0.78 0.67 0.66 0.67 0.69 0.63 0.76 0.90 0.79 0.82 0.80 0.61 0.61

The fixed asset turnover ratio for Pediatrix Medical Group Inc has remained relatively stable over the past eight quarters, ranging between 26.37 and 27.31. This indicates that the company generates approximately $26.37 to $27.31 in revenue for every dollar invested in fixed assets. A high fixed asset turnover ratio suggests efficiency in utilizing fixed assets to generate sales.

On the other hand, the total asset turnover ratio has shown a slight increasing trend, fluctuating between 0.83 and 0.90 over the same period. This ratio represents how well the company is utilizing all assets, both fixed and current, to generate revenue. An increasing total asset turnover ratio could suggest improved efficiency in asset management and generating sales from all types of assets.

Overall, Pediatrix Medical Group Inc appears to be efficiently utilizing both fixed and total assets to generate revenue, as indicated by the consistent high fixed asset turnover and the improving trend in total asset turnover ratios over the analyzed quarters.